CClinicalTrials.gg
CompletedNCT06816576Updated Jan 5, 2026

The Effect of Emotional Freedom Techniques Application on Patients With Cancer Phobia

An interventional study of Emotional Freedom Technique in Postoperative Complications, Emotion Regulation and Death Anxiety, sponsored by Bitlis Eren University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-05.

Sponsored by Bitlis Eren University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim is to examine the effect of Emotional Freedom Technique on death anxiety in patients with postoperative cancer phobia.

The hypotheses of the study are as follows:

H0: Emotional Freedom Technique has no effect on postoperative death anxiety in patients with cancer phobia.

H1: Emotional Freedom Technique has a positive effect on postoperative death anxiety in patients with cancer phobia.

Read the detailed description

Intervention Group

After coming to the clinic after surgery and after their condition was stable, the patients were given the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale as a pre-test. The researchers provided Emotional Freedom Technique (EFT) training to the patients and asked them to apply Emotional Freedom Technique. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test.

Control Group

After coming to the clinic after surgery and after their condition was stable, the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a pre-test. No intervention was made to the control group patients outside the clinical protocol. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test.

02

Conditions studied

  • Postoperative Complications
  • Emotion Regulation
  • Death Anxiety

Keywords

  • Death Anxiety
  • postoperative
  • Emotional Freedom Technique
  • cancer phobia
03

In context

Postoperative Complications

1,233 studies on the registry are indexed under Postoperative Complications; 292 are open to participants now.

This study's enrollment of 120 is close to the median of 119 across 689 interventional studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

Bitlis Eren University is the lead sponsor of 48 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Being over 18 years of age,
  • Having had oncological surgery,
  • Having no visual or auditory problems,
  • Having no psychiatric problems.

Exclusion criteria

Exclusion Criteria:

  • Not accepting to participate in the study or wanting to leave,
  • Being under 18 years of age,
  • Having been previously diagnosed with cancer.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Intervention Group

    After coming to the clinic after surgery and after their condition was stable, the patients were given the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale as a pre-test. The researchers provided EFT training to the patients and asked them to apply EFT. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test.

    Other: Emotional Freedom Technique

  • No intervention
    Control Group

    After coming to the clinic after surgery and after their condition was stable, the patient introduction form, subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a pre-test. No intervention was made to the control group patients outside the clinical protocol. After an average of 3 days, the subjective discomfort unit, cancer anxiety scale and death anxiety scale were applied as a post-test.

Interventions

  • OtherEmotional Freedom Technique

    Emotional Freedom Technique application; It is an application that works on cognitive and energetic levels. Emotional Freedom Technique Application Instructions 1. Determination of Subjective Units of Disturbance (SUD) 2. Preparation or setup 3. Application of appropriate acupuncture points in order 4. 9-Gamut: An application that allows the two hemispheres of the brain to be stimulated simultaneously 5. Application of appropriate acupuncture points in order again 6. Control of the differentiation in the level of discomfort with Subjective Units of Disturbance again

06

What researchers measure

Primary outcomes

  1. death anxiety

    Death Anxiety Scale: The scale developed by Templer was translated into Turkish by Sarıkaya and Baloğlu. The scale consists of 20 items. High scores indicate high death anxiety.

    Time frame: After coming to the clinic after surgery and their condition becoming stable, the death anxiety scale was applied to the patients as a pre-test. Three days later, the death anxiety scale was applied as a post-test.

07

Study locations

1 site
  • Bitlis Eren University
    Bitlis, 13100, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06816576
Lead sponsor
Bitlis Eren University
Responsible party
Serafettin Okutan (Principal Investigator, Assistant Professor Şerafettin OKUTAN, Surgical Nursing, Faculty of Health Sciences, Bitlis Eren University, Bitlis Eren University) — Principal investigator
First posted
Feb 10, 2025
Start date
Feb 10, 2025
Primary completion
Sep 28, 2025
Completion
Oct 10, 2025
Last update
Jan 5, 2026

Study contacts

Şerafettin OKUTAN, Dr.
principal investigator · Bitlis Eren University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion